EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Familial SYNGAP1 variants define the boundaries of a complex neurodevelopmental disorder with epilepsy

Alicia G Harrison, Jan H Magielski, Ian McSalley, Shiva Ganesan, Anna J Prentice, Kristin G Cunningham, Samuel R Pierce, Michael J Boland, Benjamin L Prosser iD, Ingo Helbig, Jillian L McKee iD

Epilepsia · 2025

DOI: 10.1111/epi.18469 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Alicia G Harrison und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: ras GTPase-Activating Proteins, Neurodevelopmental Disorders, Epilepsy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, Pediatric Epilepsy Research Foundations, American Brain Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

SYNGAP1 ‐related disorders are common neurodevelopmental conditions characterized by autism spectrum disorder, developmental delay, intellectual disability, and a range of generalized seizure types. Disease‐causing variants in SYNGAP1 typically occur de novo . This study aims to characterize inherited cases of SYNGAP1 ‐related disorders.

Methods

Here we report three families including eight total individuals with inherited, protein‐truncating variants in SYNGAP1 , recruited through a natural history study. In two of the families, the proband inherited their pathogenic variant from a heterozygous parent. In the remaining family, the variant was inherited from a mosaic parent. This study additionally reports two families with inherited missense variants classified as variants of uncertain significance, which are not clearly diagnostic at this time.

Results

Phenotypes in affected children and parents included both typical and attenuated SYNGAP1 presentations, including a single individual with a mosaic SYNGAP1 variant who was clinically unaffected. Among the individuals with protein‐truncating variants, generalized epilepsy was observed in six individuals, autism spectrum disorder in two individuals, and developmental delay or intellectual disability in all individuals with germline variants. Significance We demonstrate that SYNGAP1 ‐related disorder can occur in families and that clinical presentations of familial cases are not limited to milder phenotypes. We estimate that 3% of cases of SYNGAP1‐ related disorder are inherited. Recognition of familial SYNGAP1 ‐related disorders delineates edge cases of a relatively common neurodevelopmental disorder and has implications for variant interpretation and clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ras GTPase-Activating ProteinsNeurodevelopmental DisordersEpilepsyHumansMaleFemaleChildChild, PreschoolPedigreeAutism Spectrum DisorderDevelopmental DisabilitiesIntellectual DisabilityAdolescentPhenotypeAdult

Stichwörter der Autor:innen

SYNGAP1ACMG variant classificationdevelopmental and epileptic encephalopathyeyelid myocloniageneralized epilepsysynapse disorders

Substanzen

SYNGAP1 protein, humanras GTPase-Activating Proteins

Autor:innen und Institutionen

  • Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • The Epilepsy NeuroGenetics Initiative (ENGIN), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Center for Epilepsy and Neurodevelopmental Disorders (ENDD), Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Biomedical and Health Informatics (DBHi), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Physiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Benjamin L Prosser, Jillian L McKee

Förderung

  • NINDS NIH HHS
  • Pediatric Epilepsy Research Foundations
  • American Brain Foundation
  • National Institute for Neurological Disorders and Stroke
  • American Epilepsy Society
  • SynGAP Research Fund
  • Center for Epilepsy and Neurodevelopmental Disorders (ENDD)
  • the Epilepsy Foundation

Zitieren

APA

Harrison, A. G., Magielski, J. H., McSalley, I., Ganesan, S., Prentice, A. J., Cunningham, K. G., Pierce, S. R., Boland, M. J., Prosser, B. L., Helbig, I., & McKee, J. L. (2025). Familial SYNGAP1 variants define the boundaries of a complex neurodevelopmental disorder with epilepsy. Epilepsia. https://doi.org/10.1111/epi.18469

Vancouver

Harrison AG, Magielski JH, McSalley I, Ganesan S, Prentice AJ, Cunningham KG, et al. Familial SYNGAP1 variants define the boundaries of a complex neurodevelopmental disorder with epilepsy. Epilepsia. 2025. doi:10.1111/epi.18469

BibTeX
@article{Harrison2025,
  author = {Harrison, Alicia G and Magielski, Jan H and McSalley, Ian and Ganesan, Shiva and Prentice, Anna J and Cunningham, Kristin G and Pierce, Samuel R and Boland, Michael J and Prosser, Benjamin L and Helbig, Ingo and McKee, Jillian L},
  title = {Familial SYNGAP1 variants define the boundaries of a complex neurodevelopmental disorder with epilepsy},
  journal = {Epilepsia},
  year = {2025},
  doi = {10.1111/epi.18469}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche